Trial Profile
Effects of gentamicin on risk of systemic neurotoxic effect of botulinum toxin A
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Gentamicin
- Indications Neurogenic bladder; Urinary tract infections
- Focus Adverse reactions
- 21 Aug 2015 New trial record
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.